ArticleJournal of general internal medicine2006
Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey.
Article in Journal of general internal medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 24 citations in OpenAlex.
- The Clinical Efficacy of Prostate Cancer Screening in Worldwide and Iran: Narrative Review.World journal of oncology · 2018Review
- Role of S100A3 in human colorectal cancer and the anticancer effect of cantharidinate.Experimental and therapeutic medicine · 2013Article
- Health disparities in clinical practice patterns for prostate cancer screening by geographic regions in the United States: a multilevel modeling analysis.Prostate cancer and prostatic diseases · 2013Article
- Exploring patient perceptions of PSA screening for prostate cancer: risks, effectiveness, and importance.Canadian family physician Medecin de famille canadien · 2012Article
- Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer.BJU international · 2012Article
- Prostate cancer screening trends in a large, integrated health care system.The Permanente journal · 2012Article
- Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2011Article
- Physicians' attitudes about shared decision making for prostate cancer screening.Family medicine · 2011Article
- The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study.BMC family practice · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundThere is inconclusive evidence that prostate cancer screening with prostate-specific antigen (PSA) reduces mortality. Although PSA testing is widespread, it is unknown how many physicians have taken the PSA test themselves.
objectiveTo determine the prevalence of PSA testing among physicians.
designCross-sectional survey. SUBJECTS: A nationwide stratified random sample of urologists (response rate 61%, n=247), Internists (response rate 51%, n=273), and family physicians (response rate 64%, n=249) were surveyed by mail in 2000. After excluding female respondents and men who either reported a positive history of prostate cancer or did not respond to that query, there were 146 urologists, 96 Internists, and 118 family physicians. MEASUREMENTS: Whether physicians had undergone prostate cancer screening with PSA.
resultsEighty-seven percent (155/178) of male physicians aged, 50 and older and 21% (31/150) of white male physicians under age 50 reported having had a PSA test. More urologists than nonurologists in both age groups reported having had a screening PSA test.
conclusionMost physicians aged 50 and older report undergoing PSA testing. This may reflect a belief in its efficacy and contribute to its widespread use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.